Hydroxyprogesterone Hexanoate
Therapeutic agent (verify pharmacological class)
What it is used for
Abnormal endometrial bleeding; habitual abortion; threatened abortion; amenorrhoea; corpus luteum insufficiency sterility. Clinical selection for Hydroxyprogesterone Hexanoate should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
Hypersensitivity reactions; changes in libido; acne; GI disturbances; weight gain; break-through bleeding; breast changes; mental depression; and fluid retention.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.